Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|December 23, 2022
Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinomaTaihang Shao, Mingye Zhao, Wenxi Tang
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2023
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug PricingTaihang Shao, Mingye Zhao, Leyi Liang, et al.
BMC Cancer|July 2, 2025
Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysisMingye Zhao, Yunlin Jiang, Taihang Shao, et al.
Frontiers in Immunology|November 17, 2022
A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancerTaihang Shao, Mingye Zhao, Leyi Liang, et al.
Health Economics Review|April 11, 2025
Safety, efficacy, and cost-effectiveness evaluation of systemic treatments for refractory colorectal cancer: a systematic review and modeling studyMingye Zhao, Yunlin Jiang, Taihang Shao, et al.
Frontiers in Public Health|September 1, 2022
Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in ChinaTaihang Shao, Yinan Ren, Mingye Zhao, et al.
Frontiers in Public Health|March 13, 2023
Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential modelMingye Zhao, Taihang Shao, Zhuoyuan Chi, et al.
Frontiers in Pharmacology|October 17, 2022
Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysisMingye Zhao, Taihang Shao, Yinan Ren, et al.
BMC Public Health|August 11, 2023
Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for ChinaLeyi Liang, Taihang Shao, Hao Li, et al.
Pharmacoeconomics - Open|February 9, 2023
Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067Taihang Shao, Mingye Zhao, Leyi Liang, et al.
Pageof 3